Jos H. Beijnen - Concepedia

Author

Jos H. Beijnen

Also Known As

J H Beijnen, Jos H. Beijnen, Jos H. Beijnen

Publications

575

Citations

H-Index

Concepts

All Affiliations

Jos H. Beijnen is an author at The Netherlands Cancer Institute specializing in pharmacokinetics, pharmacotherapy, and medicine.

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	115
2	Pharmacology	2	2	115
3	Health Sciences	1	1	80
4	Pathology	1	1	80
5	Drug Development	1	1	80

Jos H. Beijnen

Publications

508

Citations

H-Index

Page 1

	Year	Citations
Substantial excretion of digoxin via the intestinal mucosa and prevention of long‐term digoxin accumulation in the brain by the mdrla P‐glycoprotein Ulrich Mayer, Els Wagenaar, Jos H. Beijnen, British Journal of Pharmacology	1996	279
The Role of mdr1a P-Glycoprotein in the Biliary and Intestinal Secretion of Doxorubicin and Vinblastine in Mice Judith van Asperen, Olaf van Tellingen, Jos H. Beijnen Drug Metabolism and Disposition	2000	89
Pharmacokinetics and pharmacodynamics of the novel marine-derived anticancer agent ecteinascidin 743 in a phase I dose-finding study. Charlotte van Kesteren, Esteban Cvitkovic, A. Taamma, PubMed Dose-finding StudyPharmaceutical ScienceOncologyMedicineSevere Thrombocytopenia	2000	80
Pharmacokinetics and pharmacodynamics of topotecan given on a daily-times-five schedule in phase II clinical trials using a limited-sampling procedure L.J.C. van Warmerdam, Geert‐Jan Creemers, Sjoerd Rodenhuis, Cancer Chemotherapy and Pharmacology Therapeutic Drug MonitoringLimited-sampling ProcedureDaily-times-five ScheduleMedicinePharmacotherapy	1996	35
Population pharmacokinetics of thioTEPA and its active metabolite TEPA in patients undergoing high‐dose chemotherapy Alwin D. R. Huitema, Ron A. A. Mathôt, Matthijs M. Tibben, British Journal of Clinical Pharmacology	2001	25

Page 1